MRNA

Moderna
D

MRNA

Who owns Moderna?

Institutions own 82.2% of Moderna's shares, through 866 funds, banks and other managers that report their holdings to the SEC; individual investors and others hold the rest. The largest on 30 June 2026 were FMR LLC (13.1%), BlackRock, Inc. (7.7%), Vanguard Capital Management LLC (5.9%).

Institutions own
82.2%
Institutional holders
866
The 10 largest hold
51.7%
Free float
93.3%
Holdings as of
30 Jun 2026

Who owns the shares

10 largest holders 51.7% Other institutions 30.5% Individuals and others 17.8%

Shares free to trade

Free float 377.37M shares ·93.3% Closely held 27.26M shares ·6.7%

Closely held shares belong to insiders, founders and owners of more than 5%, and seldom change hands. The free float is the rest: the shares anyone can buy and sell.

The largest shareholders

#HolderSharesOf the companyValueChange last quarter (shares)
1FMR LLC51,859,89113.10%3.63B USD+6,187,867
2BlackRock, Inc.30,599,4097.73%2.14B USD+963,533
3Vanguard Capital Management LLC23,208,7925.86%1.63B USD+336,334
4Capital World Investors22,276,9965.63%1.56B USD+3,579,302
5Baillie Gifford & Co18,206,7784.60%1.28B USD-1,779,098
6State Street Corp15,726,1933.98%1.10B USD+864,784
7Vanguard Portfolio Management LLC15,581,3133.93%1.09B USD-35,054
8Geode Capital Management, LLC9,710,3352.45%678.82M USD+275,203
9Morgan Stanley9,538,0942.41%667.95M USD+1,066,831
10Theleme Partners LLP8,057,5712.03%564.27M USD+9,326

All institutions last quarter

Bought or added
560 · 154 new
Sold or cut
346 · 91 sold out
Net shares bought
+15.76M · 1.10B USD
Institutional ownership
78.3% → 82.2%

Biggest buyers last quarter

  • FMR LLC+6,187,867
  • Price T Rowe Associates Inc+4,850,982
  • Sixth Street Partners Management Company, L.P.New position
  • Capital World Investors+3,579,302
  • Norges BankNew position

Biggest sellers last quarter

  • Alyeska Investment Group, L.P.-3,490,366
  • Goldman Sachs Group Inc-1,931,747
  • Two Sigma Investments, LP-1,892,874
  • Baillie Gifford & Co-1,779,098
  • Susquehanna International Group, LLP-1,341,300

From the holders' 13F filings with the SEC for the quarter to 30 Jun 2026, filed up to 45 days after it; the buyers and sellers are among the 100 largest holders.

Common questions about Moderna's shareholders

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.